MELOXICAM (MOVAL1S): THE SELECTIVE INHIBITOR OF COX-2 IN CLINICAL PRACTICE

MELOXICAM (MOVAL1S): THE SELECTIVE INHIBITOR OF COX-2 IN CLINICAL PRACTICE

Saved in:

Bibliographic Details
Main Author:	V A Nassonova
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2000-08-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/485
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2- dependent and -independent pathways.
by: Xiaofeng Dong, et al.
Published: (2014-01-01)

CARDIOVASCULAR EFFECTS OF SELECTIVE COX-2 INHIBITORS IN RHEUMATIC DISEASES
by: Rimma Mikhailovna Balabanova
Published: (2010-06-01)

Meloxicam (movalis) in a physician's practice
by: Yuliya Leonidovna Korsakova, et al.
Published: (2011-09-01)

Design and synthesis of pyridazinone hybrid in PEG-400 as COX-1/COX-2 inhibitor and their antioxidant study
by: Omprakash B. Pawar, et al.
Published: (2025-06-01)

Exploring COX-Independent Pathways: A Novel Approach for Meloxicam and Other NSAIDs in Cancer and Cardiovascular Disease Treatment
by: Lixia Cheng, et al.
Published: (2024-11-01)

Adverse Effects of COX-2 Inhibitors
by: Jagdish N. Sharma, et al.
Published: (2005-01-01)

A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example.
by: Tjeerd-Pieter van Staa, et al.
Published: (2009-12-01)

CEPHALOMETRIC SASSOUNI PLUS ANALYSIS USAGE FOR EVALUATING THE EFFECTIVENSS OF DISTAL BITE TREATMENT WITH AN ORTHODONTIC APPLIANCE WITH A MOVALE RAMP
by: P.S. Flis, et al.
Published: (2018-03-01)

Effect of Meloxicam and Nano-meloxicam on selected haematological and immunological parameters in arthritis-induced male albino rats
by: Adel Bashar, et al.
Published: (2025-06-01)

General medical aspects of the use of meloxicam (Movalis®) in clinical practice: Efficacy and safety
by: Natalia Vladimirovna Chichasova
Published: (2012-12-01)

Molecular Interaction Analysis of Homodihydrocapsaicin as COX-2 Inhibitor
by: Maria Nona Elci Lele, et al.
Published: (2022-06-01)

Melox (meloxicam) clinical efficacy in chronic joint diseases
by: Sh Erdes, et al.
Published: (2003-08-01)

CELEBREX: THE FIRST SPECIFIC INHIBITOR OF COX-2: NEW DATA
by: E L Nassonov
Published: (2000-08-01)

Meloxicam in rheumatology practice: The history of its use in the therapy of pain
by: L. I. Alekseeva, et al.
Published: (2016-06-01)

Use of meloxicam (amelotex®) in patients with gonarthrosis
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-06-01)

MELOXICAM: USE PROSPECTS IN ERYTHEMA NODOSUM
by: O N Egorova, et al.
Published: (2010-03-01)

Spectrophotometric determination of meloxicam in medicinal products
by: S. O. Vasyuk, et al.
Published: (2025-07-01)

PBOSPECTS FOR CLINICAL APPLICATION OF THE CURRENT ANTI-INFLAMMATORY DRUG MELOXICAM (AMELOTEX)
by: M S Eliseev, et al.
Published: (2008-12-01)

EVALUATION OF PROHYPERTENSIVE EFFECT OF MELOXICAM ON THE BLOOD PRESSURE INDICATORS
by: R. V. Nikiforov, et al.
Published: (2019-02-01)

What is safer for the gastrointestinal-tract: Coxibs or meloxicam?
by: A. M. Satybaldyev, et al.
Published: (2017-03-01)

Exploring the anti-cancer potential of coumarin derivatives targeting COX-2 inhibitors
by: Thanh Tin Le, et al.
Published: (2025-01-01)

Density Functional Theory and Molecular Docking Investigation of Selected NSAIDs against COX-1 and COX-2 Enzymes: Study of Correlation Between Computational and Experimental Results
by: Ateeq Ullah Jan, et al.
Published: (2025-04-01)

Use of meloxicam (Amelotex®) in patients with pyrophosphate arthropathy
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-09-01)

An old friend: 25 years of meloxicam use in Russia.
by: A. E. Karateev, et al.
Published: (2021-07-01)

Prospects for using injectable meloxicam (Amelotex®) in patients with osteoarthrosis
by: M S Eliseyev, et al.
Published: (2009-03-01)

The efficacy and safety of meloxicam (Movalis®) in the treatment of rheumatic diseases
by: Tatyana Alekseyevna Raskina, et al.
Published: (2012-06-01)

Inhibitors of Mitogen-Activated Protein Kinases Downregulate COX-2 Expression in Human Chondrocytes
by: Riina Nieminen, et al.
Published: (2005-01-01)

Use of meloxicam (Amelotex®) in patients with chronic gout to prevent
by: M S Eliseyev, et al.
Published: (2011-12-01)

Pulmonary and Cardiorenal Cyclooxygenase-1 (COX-1), -2 (COX-2), and Microsomal Prostaglandin E Synthase-1 (mPGES-1) and -2 (mPGES-2) Expression in a Hypertension Model
by: Zaher A. Radi, et al.
Published: (2007-01-01)

New Gel Approaches for the Transdermal Delivery of Meloxicam
by: Ioana-Alexandra Plugariu, et al.
Published: (2025-06-01)

Impact of Formulation Variables on Meloxicam spanlastics Preparation
by: Lubna Sabri, et al.
Published: (2024-12-01)

USE OF INJECTABLE MELOXICAM (AMELOTEX®) FORMULATION IN PATIENTS WITH GONARTHROSIS
by: M S Eliseyev, et al.
Published: (2009-09-01)

Computational identification of dual COX-1 and NIK inhibitors from marine microalga Chlorella vulgaris
by: Mahesh Samantaray, et al.
Published: (2025-09-01)

Local therapy of the knee osteoarthritis: results of a multicenter study of meloxicam
by: N. V. Toroptsova, et al.
Published: (2023-07-01)

MELOXICAM: WHAT DO WE KNOW ABOUT CARDIOVASCULAR SAFETY?
by: M S Eliseev, et al.
Published: (2010-03-01)

The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2 Synthase
by: Mohammad Asif
Published: (2014-01-01)

Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin
by: Muhammad Suleman, et al.
Published: (2025-07-01)

Celecoxib, etoricoxib, meloxicam, and nimesulide: comparison of their merits and demerits
by: Andrey Evgen'evich Karateev, et al.
Published: (2011-06-01)

Meloxicam Alleviates Oxidative Stress Through Nrf2/HO-1 Activation in Bovine Endometrial Epithelial Cells
by: Luying Cui, et al.
Published: (2025-06-01)

Pharmacoeconomic analysis of the use of movalis (meloxicam) in patients with nonspecific back pain
by: O. N. Gerasimova, et al.
Published: (2011-12-01)